LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 100 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,068,387 | -54.3% | 2,815,034 | -4.0% | 0.00% | -100.0% |
Q2 2023 | $6,712,377 | -16.5% | 2,931,169 | -11.3% | 0.00% | 0.0% |
Q1 2023 | $8,034,000 | +128279.7% | 3,305,991 | +0.9% | 0.00% | 0.0% |
Q4 2022 | $6,258 | -99.9% | 3,276,798 | +1.6% | 0.00% | 0.0% |
Q3 2022 | $7,743,000 | +267.5% | 3,226,433 | +184.8% | 0.00% | – |
Q2 2022 | $2,107,000 | -10.7% | 1,132,777 | +0.3% | 0.00% | – |
Q1 2022 | $2,360,000 | -47.8% | 1,129,321 | -1.6% | 0.00% | -100.0% |
Q4 2021 | $4,524,000 | -18.8% | 1,148,090 | -0.8% | 0.00% | 0.0% |
Q3 2021 | $5,568,000 | -7.6% | 1,157,703 | -11.8% | 0.00% | 0.0% |
Q2 2021 | $6,027,000 | +160.7% | 1,313,161 | +233.4% | 0.00% | – |
Q1 2021 | $2,312,000 | +51.5% | 393,886 | -11.7% | 0.00% | – |
Q4 2020 | $1,526,000 | +1595.6% | 446,111 | +623.1% | 0.00% | – |
Q3 2020 | $90,000 | +119.5% | 61,694 | +205.6% | 0.00% | – |
Q2 2020 | $41,000 | +5.1% | 20,191 | +0.5% | 0.00% | – |
Q1 2020 | $39,000 | -55.2% | 20,086 | -5.0% | 0.00% | – |
Q4 2019 | $87,000 | +50.0% | 21,153 | +9.2% | 0.00% | – |
Q3 2019 | $58,000 | -49.1% | 19,371 | +4.4% | 0.00% | – |
Q2 2019 | $114,000 | +29.5% | 18,550 | +17.8% | 0.00% | – |
Q1 2019 | $88,000 | -15.4% | 15,742 | +0.6% | 0.00% | – |
Q4 2018 | $104,000 | -31.1% | 15,652 | +10.9% | 0.00% | – |
Q3 2018 | $151,000 | -77.9% | 14,116 | -75.2% | 0.00% | – |
Q2 2018 | $684,000 | -20.4% | 56,985 | -43.2% | 0.00% | – |
Q1 2018 | $859,000 | -20.1% | 100,309 | -7.8% | 0.00% | – |
Q4 2017 | $1,075,000 | -16.4% | 108,826 | +4.6% | 0.00% | – |
Q3 2017 | $1,286,000 | -27.7% | 104,041 | -3.7% | 0.00% | – |
Q2 2017 | $1,778,000 | -55.3% | 108,093 | -61.1% | 0.00% | -100.0% |
Q1 2017 | $3,980,000 | -5.4% | 277,556 | -8.8% | 0.00% | 0.0% |
Q4 2016 | $4,207,000 | -20.0% | 304,210 | +4.6% | 0.00% | 0.0% |
Q3 2016 | $5,256,000 | +193.8% | 290,850 | +133.3% | 0.00% | – |
Q2 2016 | $1,789,000 | +14.3% | 124,693 | -4.8% | 0.00% | – |
Q1 2016 | $1,565,000 | -12.7% | 130,993 | -2.7% | 0.00% | – |
Q4 2015 | $1,793,000 | +21.2% | 134,693 | -2.2% | 0.00% | – |
Q3 2015 | $1,479,000 | – | 137,693 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |